Inflammation is associated with perioperative myocardial infarction (MI) and mortality following coronary artery bypass graft (CABG) surgery, but it is not known whether pharmacologic intervention to block proinflammatory physiologic responses might improve CABG surgery outcomes. Verrier and colleagues report results of a randomized, placebo-controlled trial of pexelizumab, an inhibitor of complement activation, in patients undergoing CABG surgery. For their primary end point of death or MI within 30 days of CABG surgery (without concomitant valve surgery), the authors found a nonstatistically significant benefit of pexelizumab compared with placebo. In analyses examining reductions in risk for all CABG surgery patients and for the risk of perioperative MI alone, pexelizumab was superior to placebo.
Cases of acute renal failure from ischemia and from radiographic contrast are believed to have similar origins, and in animal models of ischemic renal failure, pretreatment with sodium bicarbonate appears to be protective. However, whether sodium bicarbonate might prevent contrast-induced nephropathy has not been determined. Merten and colleagues Article conducted a randomized trial in which patients with renal insufficiency received either sodium chloride or sodium bicarbonate infusions before and after procedures involving radiocontrast. The investigators found a significantly reduced risk of contrast-induced nephropathy in patients receiving sodium bicarbonate hydration. In an editorial, Article Chertow reviews prior strategies to prevent contrast-induced nephropathy and the demonstrated benefits of sodium bicarbonate.
Hematopoietic cell transplantation (HCT) can be curative for some patients with leukemia and lymphoma, but factors predicting the time course of physical and emotional recovery after HCT have not been well defined. Syrjala and colleagues assessed physical limitations, mental health, and return to work in a 5-year, longitudinal follow-up of patients undergoing HCT. They found that only 19% of patients had recovered within the first year, and most patients required 3 to 5 years to recover. Greater social support and experience with cancer treatment before HCT were associated with a more rapid recovery. Those who were depressed before HCT had a longer recovery time.
Increasing pharmacy co-payments is one way health plans have responded to the increase in expenditures for drugs, but it is not known how changes in cost-sharing affect the use of commonly prescribed drugs. Goldman and colleagues analyzed pharmacy claims data and health plan benefits to examine the relationship of rising co-payments with drug use. They found that a doubling of the copayment resulted in significant reductions in the use of drugs in 8 common therapeutic drug classes. The greatest reductions were seen for possibly "nonessential" nonsteroidal anti-inflammatory drugs and antihistamines and drugs with an over-the-counter substitute.
For a 2-month period in 1999, it was recommended that the usual birth dose of hepatitis B vaccine be delayed until 2 to 6 months of age. Using data from the National Immunization Survey for children born before, during, and after the birth-dose vaccination suspension, Luman and colleagues assessed the effect of this change in vaccine administration on hepatitis—and overall pediatric—vaccination coverage. They found a significant decline in the proportion of infants who received the hepatitis B vaccine at birth and who completed the 3-dose series by age 19 months, beginning during the suspension period and persisting after the suspension was lifted but no declines in other recommended vaccinations.
Some chemical modifications to an individual's DNA can silence genes that normally safeguard against cancer. Scientists are exploring how to shut down cancer cells by awakening these silenced genes.
Clinical Review
Intravenous immunoglobulin (IVIG) is effective in treating many autoimmune neuromuscular diseases.
Grahic Jump Location
The Patient-Physician Relationship
Methods for communicating clinical evidence to enhance patient participation in care decisions are discussed.
From the Archives Journals
Improvements in speech and language development in children undergoing early cochlear implant placement are reported on in the Archives of Otolaryngology–Head & Neck Surgery.
For your patients: Information about cochlear implants.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.